Biosino Bio-Technology and Science Incorporation (HKG:8247)

HKG:8247 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	504	327	110	116	184	246
Market Cap Growth	309.41%	197.37%	-5.00%	-37.01%	-25.29%	1.19%
Enterprise Value	627	437	250	252	316	443
Last Close Price	3.48	2.26	0.76	0.80	1.27	1.70
PE Ratio	-	-	-	-	20.06	-
PS Ratio	2.46	1.60	0.39	0.36	0.44	0.58
PB Ratio	4.01	2.60	0.59	0.45	0.69	1.00
P/TBV Ratio	4.25	2.76	0.69	0.55	0.89	1.30
P/FCF Ratio	-	-	9.10	-	5.77	4.44
P/OCF Ratio	-	-	4.35	-	3.65	4.10
EV/Sales Ratio	3.06	2.13	0.89	0.79	0.75	1.04
EV/EBITDA Ratio	-	-	-	-	6.84	7.23
EV/EBIT Ratio	-	-	-	-	14.18	14.23
EV/FCF Ratio	-17.41	-	20.65	-	9.93	8.00
Debt / Equity Ratio	1.44	1.44	0.88	0.65	0.65	0.87
Debt / EBITDA Ratio	-	-	-	231.22	3.47	3.27
Debt / FCF Ratio	-	-	13.54	-	5.38	3.84
Net Debt / Equity Ratio	1.05	1.05	0.45	0.34	0.29	0.62
Net Debt / EBITDA Ratio	-3.11	-3.11	-3.47	-33.71	1.65	2.46
Net Debt / FCF Ratio	-3.66	-3.66	6.94	-3.46	2.39	2.72
Asset Turnover	0.42	0.42	0.51	0.50	0.62	0.56
Inventory Turnover	2.33	2.33	2.71	2.79	3.93	3.26
Quick Ratio	0.54	0.54	0.67	0.79	0.87	0.66
Current Ratio	0.82	0.82	0.97	1.09	1.15	1.05
Return on Equity (ROE)	-45.25%	-45.25%	-28.03%	-8.27%	6.55%	1.60%
Return on Assets (ROA)	-7.61%	-7.61%	-4.48%	-2.08%	2.04%	2.57%
Return on Invested Capital (ROIC)	-23.26%	-22.21%	-13.22%	-6.34%	4.86%	3.74%
Return on Capital Employed (ROCE)	-42.50%	-42.50%	-20.20%	-8.00%	7.70%	11.60%
Earnings Yield	-11.30%	-17.40%	-41.16%	-11.09%	4.99%	-0.57%
FCF Yield	-7.16%	-11.02%	10.99%	-21.80%	17.34%	22.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.